Okine, L.K.Dofuor, A.K.Kwain, S.Osei, E.Tetevi, G.M.Ohashi, M.Gwira, T.M.Kyeremeh, K.2019-09-272019-09-272019-07-03doi:10.3390/M1070http://ugspace.ug.edu.gh/handle/123456789/32318Research ArticleAbstract: The plant Zanthoxylum zanthoxyloides (Lam.) Zepern. & Timler is one of the most important medicinal species of the genus Zanthoxylum on the African continent. It is used in the treatment and management of parasitic diseases in sub-Saharan Africa. These properties have inspired scientists to investigate species within the genus for bioactive compounds. However, a study, which details a spectroscopic, spectrometric and bioactivity guided extraction and isolation of antiparasitic compounds from the genus Zanthoxylum is currently non-existent. Tortozanthoxylamide (1), which is a derivative of the known compound armatamide was isolated from Z. zanthoxyloides and the full structure determined using UV, IR, 1D/2D-NMR and high-resolution liquid chromatography tandem mass spectrometry (HRESI-LC-MS) data. When tested against Trypanosoma brucei subsp. brucei, the parasite responsible for animal African trypanosomiasis in sub-Saharan Africa, 1 (IC50 7.78 M) was just four times less active than the commercially available drug diminazene aceturate (IC50 1.88 M). Diminazene aceturate is a potent drug for the treatment of animal African trypanosomiasis. Tortozanthoxylamide (1) exhibits a significant antitrypanosomal activity through remarkable alteration of the cell cycle in T. brucei subsp. brucei, but it is selectively non-toxic to mouse macrophages RAW 264.7 cell lines. This suggests that 1 may be considered as a sca old for the further development of natural antitrypanosomal compounds.enTrypanosomiasisAntitrypanosomalsCell cycleCell viabilityZanthoxylumRutaceae1,3-benzodioxoleSpectroscopyArticle